Results 161 to 170 of about 885,970 (344)
The effect of ABO blood groups on the incidence of epidemic influenza and on the response to live attenuated and detergent split influenza virus vaccines [PDF]
, 1978 J. S. Mackenzie, Peter J. Fimmel
openalex +1 more source
Exploring the Potential and Advancements of Circular RNA Therapeutics
Exploration, EarlyView.Given the remarkable advantages in terms of stability, sustained expression profile, safety, wide range of druggable targets, scalable and cost‐effective manufacturing capabilities, circRNA is currently undergoing intensive investigation for various therapeutic applications such as vaccines, protein replacement, genetic disease treatment, gene therapy,
Lei Wang +6 more
wiley +1 more source
A surface antigen influenza vaccine: 2. Pyrogenicity and antigenicity [PDF]
, 1976 Margaret I. Brady, I. Furminger
openalex +1 more source
Influenza infections during pregnancy: association with congenital malformations and with subsequent neoplasms in children, and potential hazards of live virus vaccines. [PDF]
, 1974 J. S. Mackenzie, M Houghton
openalex +2 more sources
Response to influenza vaccine in adjuvant 65-4 [PDF]
, 1975 J. W. G. Smith +4 more
openalex +1 more source
Harnessing the therapeutic potential of bacterial extracellular vesicles via functional peptides
Interdisciplinary Medicine, EarlyView.Bacterial extracellular vesicles (BEVs) are increasingly exploited as therapeutic agents or delivery vehicles for disease treatment due to their intrinsic structure, delivery capacity, immunogenic property, facile production, and versatile modification.
Yejiao Shi +3 more
wiley +1 more source
Enhanced Immunogenicity in Mice of a Purified, Tween-Ether-Treated Influenza Vaccine [PDF]
, 1970 James D. Fenters +3 more
openalex +1 more source